MediWound (MDWD) Shares Outstanding (Weighted Average) (2016 - 2025)

MediWound has reported Shares Outstanding (Weighted Average) over the past 10 years, most recently at $12.8 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $12.8 million for Q4 2025, up 18.92% from a year ago — trailing twelve months through Dec 2025 was $12.8 million (up 18.92% YoY), and the annual figure for FY2025 was $12.8 million, up 18.92%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $12.8 million at MediWound, up from $10.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for MDWD hit a ceiling of $12.8 million in Q4 2025 and a floor of $3.9 million in Q4 2021.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $9.0 million (2023), compared with a mean of $8.3 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): crashed 85.71% in 2021 and later surged 80.73% in 2023.
  • MediWound's Shares Outstanding (Weighted Average) stood at $3.9 million in 2021, then increased by 28.13% to $5.0 million in 2022, then surged by 80.73% to $9.0 million in 2023, then increased by 19.75% to $10.8 million in 2024, then increased by 18.92% to $12.8 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $12.8 million (Q4 2025), $10.8 million (Q4 2024), and $9.0 million (Q4 2023) per Business Quant data.